ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,795.70
-0.67%
S&P ASX All Technology
3,108.50
1.09%
Brent Oil
81.16
-0.45%
US Dollar vs AUD
1.51121
0.03%
Bitcoin
69,428.12
0.47%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Pivotal Therapeutics Inc (CE) (PVTTF)

  7. Pivotal Therapeutics Inc (CE) (PVTTF) News

PVTTF

Pivotal Therapeutics (CE) (PVTTF)

Pivotal Therapeutics Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:PVTTF
DateTimeSourceHeadlineSymbolCompany
06/05/201407:22MarketwiredCrossover Healthcare Fund Announces Ownership Interest in Pivotal Therapeutics Inc.USOTC:PVTTFPivotal Therapeutics Inc (CE)
08/10/201307:39OTC MarketsPivotal Therapeutics receives CDN $1.65 million in debt financing; Company closes equity portion of financing; over CDN $4.3 ...USOTC:PVTTFPivotal Therapeutics Inc (CE)
08/10/201307:39OTC MarketsPivotal Therapeutics receives CDN $1.65 million in debt financing; Company closes equity portion of financing; over CDN $4.3 ...USOTC:PVTTFPivotal Therapeutics Inc (CE)
02/10/201322:54OTC MarketsPivotal Therapeutics to close equity portion of financing; Enters into $5,000,000 debt financing agreementUSOTC:PVTTFPivotal Therapeutics Inc (CE)
02/10/201322:54OTC MarketsPivotal Therapeutics to close equity portion of financing; Enters into $5,000,000 debt financing agreementUSOTC:PVTTFPivotal Therapeutics Inc (CE)
14/09/201303:49OTC MarketsManagement Discussion and AnalysisUSOTC:PVTTFPivotal Therapeutics Inc (CE)
14/09/201303:46OTC MarketsInterim Financial ReportUSOTC:PVTTFPivotal Therapeutics Inc (CE)
06/09/201302:45OTC MarketsPIVOTAL THERAPEUTICS ANNOUNCES SECOND QUARTER 2013 FINANCIAL RESULTS AND CORPORATE UPDATEUSOTC:PVTTFPivotal Therapeutics Inc (CE)
31/08/201305:24OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
31/08/201305:15OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
31/08/201305:11OTC MarketsQuarterly ReportUSOTC:PVTTFPivotal Therapeutics Inc (CE)
31/08/201305:06OTC MarketsInterim Financial ReportUSOTC:PVTTFPivotal Therapeutics Inc (CE)
31/05/201314:44OTC MarketsAnnual ReportUSOTC:PVTTFPivotal Therapeutics Inc (CE)
31/05/201314:41OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
31/05/201314:33OTC MarketsProxy MaterialsUSOTC:PVTTFPivotal Therapeutics Inc (CE)
31/05/201314:31OTC MarketsProxy MaterialsUSOTC:PVTTFPivotal Therapeutics Inc (CE)
31/05/201314:29OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/05/201313:51OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/05/201313:49OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/05/201313:38OTC MarketsInterim Financial ReportUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/05/201313:20OTC MarketsQuarterly ReportUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/05/201302:34OTC MarketsPivotal Therapeutics Announces First Quarter 2013 Financial ResultsUSOTC:PVTTFPivotal Therapeutics Inc (CE)
08/05/201300:55OTC MarketsPivotal Therapeutics VASCAZEN®-REVEAL trial meets primary and secondary endpoints - VASCAZEN® shows 121% correction o...USOTC:PVTTFPivotal Therapeutics Inc (CE)
03/05/201302:07OTC MarketsPivotal's Founder and Chairman Dr. George Jackowski receives Queen Elizabeth II Diamond Jubilee MedalUSOTC:PVTTFPivotal Therapeutics Inc (CE)
01/05/201308:08OTC MarketsPivotal Therapeutics VASCAZEN® - REVEAL Trial Top Line Results to be presented at American Heart Association's Arterioscl...USOTC:PVTTFPivotal Therapeutics Inc (CE)
30/04/201312:08OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/04/201312:07OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/04/201312:02OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/04/201312:00OTC MarketsManagement Discussion and AnalysisUSOTC:PVTTFPivotal Therapeutics Inc (CE)
30/04/201310:38OTC MarketsPivotal Therapeutics Announces 2012 Financial ResultsUSOTC:PVTTFPivotal Therapeutics Inc (CE)
 Showing the most relevant articles for your search:USOTC:PVTTF

Your Recent History

BIT
MB
Mediobanca Banca di Cred...
USOTC
KFFLF
KEFI Gold and Copper (PK)
NASDAQ
VRM
Vroom
BIT
P1V9H2
NLBNPIT1V9H2 20991231 28...
EU
QEVT
SPEAR Investments
EU
AAG4L
Credit Agricole Sa null
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved